224 related articles for article (PubMed ID: 17026767)
1. Insights into the evolution of the ErbB receptor family and their ligands from sequence analysis.
Stein RA; Staros JV
BMC Evol Biol; 2006 Oct; 6():79. PubMed ID: 17026767
[TBL] [Abstract][Full Text] [Related]
2. Negative constraints underlie the ErbB specificity of epidermal growth factor-like ligands.
van der Woning SP; van Rotterdam W; Nabuurs SB; Venselaar H; Jacobs-Oomen S; Wingens M; Vriend G; Stortelers C; van Zoelen EJ
J Biol Chem; 2006 Dec; 281(52):40033-40. PubMed ID: 17032651
[TBL] [Abstract][Full Text] [Related]
3. Epidermal growth factor contains both positive and negative determinants for interaction with ErbB-2/ErbB-3 heterodimers.
Stortelers C; van De Poll ML; Lenferink AE; Gadellaa MM; van Zoelen C; van Zoelen EJ
Biochemistry; 2002 Apr; 41(13):4292-301. PubMed ID: 11914075
[TBL] [Abstract][Full Text] [Related]
4. Phosphotyrosine interactome of the ErbB-receptor kinase family.
Schulze WX; Deng L; Mann M
Mol Syst Biol; 2005; 1():2005.0008. PubMed ID: 16729043
[TBL] [Abstract][Full Text] [Related]
5. Role of the N-terminus of epidermal growth factor in ErbB-2/ErbB-3 binding studied by phage display.
Stortelers C; Souriau C; van Liempt E; van de Poll ML; van Zoelen EJ
Biochemistry; 2002 Jul; 41(27):8732-41. PubMed ID: 12093292
[TBL] [Abstract][Full Text] [Related]
6. Control of ErbB signaling through metalloprotease mediated ectodomain shedding of EGF-like factors.
Sanderson MP; Dempsey PJ; Dunbar AJ
Growth Factors; 2006 Jun; 24(2):121-36. PubMed ID: 16801132
[TBL] [Abstract][Full Text] [Related]
7. Bivalence of EGF-like ligands drives the ErbB signaling network.
Tzahar E; Pinkas-Kramarski R; Moyer JD; Klapper LN; Alroy I; Levkowitz G; Shelly M; Henis S; Eisenstein M; Ratzkin BJ; Sela M; Andrews GC; Yarden Y
EMBO J; 1997 Aug; 16(16):4938-50. PubMed ID: 9305636
[TBL] [Abstract][Full Text] [Related]
8. Structural requirements for ErbB2 transactivation.
Penuel E; Schaefer G; Akita RW; Sliwkowski MX
Semin Oncol; 2001 Dec; 28(6 Suppl 18):36-42. PubMed ID: 11774204
[TBL] [Abstract][Full Text] [Related]
9. EGFR kinase possesses a broad specificity for ErbB phosphorylation sites, and ligand increases catalytic-centre activity without affecting substrate binding affinity.
Fan YX; Wong L; Johnson GR
Biochem J; 2005 Dec; 392(Pt 3):417-23. PubMed ID: 16122376
[TBL] [Abstract][Full Text] [Related]
10. Selective formation of ErbB-2/ErbB-3 heterodimers depends on the ErbB-3 affinity of epidermal growth factor-like ligands.
Stortelers C; van der Woning SP; Jacobs-Oomen S; Wingens M; van Zoelen EJ
J Biol Chem; 2003 Apr; 278(14):12055-63. PubMed ID: 12556529
[TBL] [Abstract][Full Text] [Related]
11. Epigen, the last ligand of ErbB receptors, reveals intricate relationships between affinity and mitogenicity.
Kochupurakkal BS; Harari D; Di-Segni A; Maik-Rachline G; Lyass L; Gur G; Kerber G; Citri A; Lavi S; Eilam R; Chalifa-Caspi V; Eshhar Z; Pikarsky E; Pinkas-Kramarski R; Bacus SS; Yarden Y
J Biol Chem; 2005 Mar; 280(9):8503-12. PubMed ID: 15611079
[TBL] [Abstract][Full Text] [Related]
12. Role of the C-terminal linear region of EGF-like growth factors in ErbB specificity.
van der Woning SP; Venselaar H; van Rotterdam W; Jacobs-Oomen S; van Leeuwen JE; van Zoelen EJ
Growth Factors; 2009 Jun; 27(3):163-72. PubMed ID: 19384683
[TBL] [Abstract][Full Text] [Related]
13. Epidermal growth factor mutant with wild-type affinity for both ErbB1 and ErbB3.
Wingens M; Jacobs-Oomen S; van der Woning SP; Stortelers C; van Zoelen EJ
Biochemistry; 2006 Apr; 45(14):4703-10. PubMed ID: 16584205
[TBL] [Abstract][Full Text] [Related]
14. The oncogenic ErbB-2/ErbB-3 heterodimer is a surrogate receptor of the epidermal growth factor and betacellulin.
Pinkas-Kramarski R; Lenferink AE; Bacus SS; Lyass L; van de Poll ML; Klapper LN; Tzahar E; Sela M; van Zoelen EJ; Yarden Y
Oncogene; 1998 Mar; 16(10):1249-58. PubMed ID: 9546426
[TBL] [Abstract][Full Text] [Related]
15. The EGF domain: requirements for binding to receptors of the ErbB family.
Van Zoelen EJ; Stortelers C; Lenferink AE; Van de Poll ML
Vitam Horm; 2000; 59():99-131. PubMed ID: 10714238
[TBL] [Abstract][Full Text] [Related]
16. The single transmembrane domains of ErbB receptors self-associate in cell membranes.
Mendrola JM; Berger MB; King MC; Lemmon MA
J Biol Chem; 2002 Feb; 277(7):4704-12. PubMed ID: 11741943
[TBL] [Abstract][Full Text] [Related]
17. Trophoblast subtype-specific EGFR/ERBB4 expression correlates with cell cycle progression and hyperplasia in complete hydatidiform moles.
Fock V; Plessl K; Fuchs R; Dekan S; Milla SK; Haider S; Fiala C; Knöfler M; Pollheimer J
Hum Reprod; 2015 Apr; 30(4):789-99. PubMed ID: 25740878
[TBL] [Abstract][Full Text] [Related]
18. Evolutionary analysis of the ErbB receptor and ligand families.
Stein RA; Staros JV
J Mol Evol; 2000 May; 50(5):397-412. PubMed ID: 10824084
[TBL] [Abstract][Full Text] [Related]
19. The leucine-rich repeat protein LRIG1 is a negative regulator of ErbB family receptor tyrosine kinases.
Laederich MB; Funes-Duran M; Yen L; Ingalla E; Wu X; Carraway KL; Sweeney C
J Biol Chem; 2004 Nov; 279(45):47050-6. PubMed ID: 15345710
[TBL] [Abstract][Full Text] [Related]
20. The crystal structure of a truncated ErbB2 ectodomain reveals an active conformation, poised to interact with other ErbB receptors.
Garrett TP; McKern NM; Lou M; Elleman TC; Adams TE; Lovrecz GO; Kofler M; Jorissen RN; Nice EC; Burgess AW; Ward CW
Mol Cell; 2003 Feb; 11(2):495-505. PubMed ID: 12620236
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]